Protagenic Therapeutics Cash Flow Reinvestment Rate
Protagenic Therapeutics cash flow reinvestment rate. Protagenic Therapeutics (PTIX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2010, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.72 Million. Explore Protagenic Therapeutics cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Protagenic Therapeutics (1999–2008)
Cash flow reinvestment rate of Protagenic Therapeutics from 1999 to 2008. Historical reinvestment intensity for Protagenic Therapeutics across 7 annual periods. Explore Protagenic Therapeutics (PTIX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Protagenic Therapeutics Cash Flow Reinvestment Rate by Year (1999–2008)
Protagenic Therapeutics cash flow reinvestment rate by year from 1999 to 2008. Year-by-year capital reinvestment analysis for Protagenic Therapeutics. For the full cash flow conversion analysis, see Protagenic Therapeutics cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.47x | $2.03 Million | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $77.00K | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.48 Million | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $1.78 Million | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $3.79 Million | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.23 Million | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $81.00K | $331.00K | $81.00K | — |